Calvista Pharmaceuticals rise after FDA nod for Ekterly (Kalv)


Blue capsules in the conveyor in a modern pharmaceutical factory. Tablets and capsule production process. Approach of the production line of medical drug production.

SweetBunfactory / Istock via Getty Images

  • Calvista Pharmacy (Nasdaq:Calf) The US FDA, 12 years and older and older adults and children began after the US FDA, plasma inhibitor, Ekterly (Sebetralstat) to treat hereditary anbioedem.
  • Staple gossip Will start in the ektherly



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *